Kala Bio vs Shuttle Pharmaceuticals
KALA and SHPH side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KALA and SHPH compare
Shuttle Pharmaceuticals is the larger company, worth 1.7 times as much as Kala Bio ($4.5M against $2.7M).
Kala Bio scores higher on the StockData Score (6 against 5 for Shuttle Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KALA | SHPH |
|---|---|---|
| Size and price | ||
| Market cap | $2.7M | $4.5M |
| Share price | $0.139 | $4.53 |
| Change, 1 year | −99.6% | −82.0% |
| Change, 5 years | −100.0% | – |
| Beta (5Y) | 0.34 | 2.21 |
| Employees | 6 | 2 |
| StockData Score | ||
| Total score | 6 (better) | 5 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/B | 0.3× | 0.2× (better) |
| Profitability | ||
| Return on equity | −345% | −90.1% (better) |
| Return on invested capital | – | −99.2% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 6.88 (better) | 0.11 |
| Altman Z-score | −96.83 | −4.20 (better) |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 3.2% | 10.4% |
| Insider net buying, 12 months | $0 (better) | −$323K |
Go deeper
- KALA stock overview
- KALA income statement
- KALA valuation and score
- SHPH stock overview
- SHPH income statement
- SHPH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.